Skip to main content

2023 SSO Annual Meeting Main banner

Tweets by 2023 SSO Annual Meeting

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Tweet

Ari M. VanderWalde, MD, MPH, FACP

Research Faculty
West Cancer Center and Research Institute, United States

Presentation(s):

60: Safety, efficacy, and biomarker assessment of RP1 in combination with nivolumab in patients with advanced skin cancers
Friday, March 24, 2023
10:54 AM – 11:04 AM
Disclosure information not submitted.